The International Bladder Cancer Update (IBCU) is a CME conference focused on the diagnosis and treatment of bladder cancer. The conference offers medical professionals an opportunity to listen to updates from, and interact with, expert international faculty to improve knowledge and determine best treatment practices to improve patient outcomes.
IBCU encompasses expert lectures, interactive discussions, a panel roundtable, debates, and case presentations. It is physician-led, multi-supported, and designed for urologists, urologic oncologists, and other healthcare professionals involved in the treatment of bladder cancer.
Vanderbilt University School of Medicine
Yale Cancer Center
New Haven, Connecticut
The 6th International Bladder Cancer Update (IBCU6) offers a robust program that encompasses expert lectures, interactive discussions, a panel roundtable, debates, and case presentations. Join us for the conference, November 18-20, 2022.
This is a working agenda and subject to change. Please check back often for the latest updates.
|Friday, November 18, 2022 (ALL TIMES PST)|
|11:00am – 6:00pm||Registration and Exhibitor Check-in|
|2:00pm – 6:00pm||Exhibits Open|
|3:00pm – 4:00pm||Industry-Supported Educational Symposium|
|4:00pm – 5:00pm||Session I – Bladder Cancer Treatment: An Evolution In Progress||Moderator: Seth P. Lerner, MD|
|4:00pm – 4:10pm||Welcome and Introduction||Sam S. Chang, MD, MBA|
|4:10pm – 4:25pm||The Contribution of SWOG to Bladder Cancer Clinical Trials||Seth P. Lerner, MD|
|4:25pm – 4:40pm||Alternative Payment Models - Value Care Bundling||C.J. Stimson, MD, JD|
|4:40pm – 5:00pm||Panel Discussion: What Does the Future Hold?||Moderator: Sam S. Chang, MD, MBA|
|5:00pm – 6:00pm||IBCU Video Poster Session|
|6:00pm – 7:00pm||IBCU Welcome Reception – Exhibit Hall|
|7:00pm – 9:00pm||Faculty Dinner|
|Saturday, November 19, 2022 (ALL TIMES PST)|
|7:00am – 8:00am||Industry-supported Educational Breakfast Symposium|
|7:00am – 12:00pm||Exhibits Open|
|8:00am – 11:00am||Session II: Management of Non-muscle Invasive Bladder||Moderator: Sam S. Chang, MD, MBA|
|8:00am – 8:10am||Welcome and Introduction||Sam S. Chang, MD, MBA|
|8:10am – 8:30am||Controversies in NMIBC: Guidelines and Beyond||Sam S. Chang, MD, MBA|
|8:30am – 8:50am||Use of Biomarkers in NMIBC: What’s New? And What Should We Use?||Peter Black, MD|
|8:50am – 9:10am||Risk Stratification: Moving from the Old to the New||Joshua J. Meeks, MD, PhD|
|9:10am – 9:30am||Break and Visit Exhibits|
|9:30am – 9:40am||Prioritizing the Optimal Therapy for T1 Bladder Cancer: Using the Old and the New To Determine What to Do||Seth P. Lerner, MD|
|9:40pm – 9:50pm||Pathology of Urothelial Cancers||Donna Hansel, MD, PhD|
|9:50am – 10:00am||Keynote Address: TBD||E. David Crawford, MD|
|10:00am – 10:20am||NMIBC Trials for BCG Naive Patients: What is Exciting||Joshua J. Meeks, MD, PhD|
|10:20am – 10:30am||Enhanced Techniques of NMIBC Detection||Mark D. Tyson, II, MD, MPH|
|10:30am – 11:00am||Panel Discussion: New Therapies for BCG Unresponsive NMIBC: Where Do We Stand?||Moderator: Sam S. Chang, MD, MBADiscussants: Peter Black, MD, Jennifer A. Linehan, MD, Joshua J. Meeks, MD, PhD, Parminder Singh, MD|
|11:00am – 12:00pm||Session III: Challenging Case Presentations||Moderator: Mark D. Tyson, II, MD, MPHDiscussants: Peter Black, MD, Jennifer A. Linehan, MD, Joshua J. Meeks, MD, PhD, Parminder Singh, MD|
|12:00pm – 1:00pm||Industry-supported Lunch Symposium|
|1:00pm – 2:30pm||Exhibits Open|
|1:00pm – 2:30pm||Session IV: Advanced Urothelial Cancer Part 1: Impact of Immunotherapy||Moderator: Daniel P. Petrylak, MD|
|1:00pm – 1:10pm||Immune Checkpoint Inhibitors||Daniel P. Petrylak, MD|
|1:10pm – 1:30pm||Immune Checkpoint Inhibitors: Combination Therapy||Jean H. Hoffman-Censits, MD|
|1:30pm – 1:50pm||Immune Checkpoint Inhibitors: Managing Immune-related Side Effects||Guru P. Sonpavde, MD|
|1:50pm – 2:00pm||Earlier Use of These Treatments Moving Into Adjuvant and NMIBC: What Do We Do About Patients for Reinduction of Immune Treatment||Guru P. Sonpavde, MD|
|2:00pm – 2:30pm||Panel Discussion: Future Challenges to the Use of Immunotherapy: What’s the Right Timing and Sequencing?||Moderator: Daniel P. Petrylak, MD|
|Afternoon / Evening||On Own|
|Sunday, November 20, 2022 (ALL TIMES PST)|
|7:00am – 8:00am||Industry-supported Breakfast Symposium|
|7:00am – 12:30pm||Exhibits Open|
|8:00am – 9:30am||Session V: Advanced Urothelial Cancer Part 2: Latest Research and Clinical Trials||Moderator: Daniel P. Petrylak, MD|
|8:00am – 8:20am||FGFR Kinase Inhibitors and Other Novel Targets in the Treatment of Metastatic Urothelial Cancer||Parminder Singh, MD|
|8:20am – 8:35am||The Use of Antibody-drug Conjugates in Treating Advanced Urothelial Cancer||Daniel P. Petrylak, MD|
|8:35am – 8:50am||Targeted Therapy Combined with Immune Checkpoint Therapy: Is This the Wave of the Future?||Jean H. Hoffman-Censits, MD|
|8:50am – 9:05am||Biomarker Integration for Advanced Urothelial Carcinoma||Donna Hansel, MD, PhD|
|9:05am – 9:30am||Panel Discussion / Questions and Answers||Moderator: Daniel P Petrylak, MDDiscussants: Donna Hansel, MD, PhD, Jean H. Hoffman-Censits, MD, Parminder Singh, MD, Guru P. Sonpavde, MD|
|9:30am – 9:50am||Break and Visit Exhibits|
|9:50am – 10:50am||Session VI: Management of UTUC||Moderator: Jennifer A. Linehan, MD|
|9:50am – 10:10am||UTUC – Is it Biologically Distinct?||Donna Hansel, MD, PhD|
|9:50am – 10:10am||Methods and Guidelines to Stage and Grade (Low vs. High) UTUC and How Should We Treat||Seth P. Lerner, MD|
|10:10am – 10:30am||Treatment of Advanced UTUC||Jennifer A. Linehan, MD|
|10:30am – 10:50am||Panel Discussion / Questions and Answers||Moderator: Jennifer A. Linehan, MDDiscussants: Peter Black, MD, Sam S. Chang, MD, MBA, Seth P. Lerner, MD, Mark D. Tyson, II, MD, MPH|
|10:50am – 12:30pm||Session VII: Management of MIBC||Moderator: Peter Black, MD|
|10:50am – 11:10am||Neoadjuvant or Adjuvant Therapy?||Parminder Singh, MD|
|11:10am – 11:30am||What Should I Do About Micropapillae? Do I treat it differently than standard?||Donna Hansel, MD, PhD|
|11:30am – 11:50am||Bladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?||Peter Black, MD|
|11:50am – 12:10pm||Utilizing Molecular Characterization of Invasive Bladder Cancer: What It Means Now and In the Future||Joshua J. Meeks, MD, PhD|
|12:10pm – 12:30pm||Panel Discussion / Questions and Answers||Moderator: Daniel P Petrylak, MD|
|12:30pm||Closing Remarks & Adjourn|
The Westin Kierland Resort & Spa
6902 East Greenway Parkway
Scottsdale, Arizona 85254
Discover a refreshing oasis at The Westin Kierland Resort & Spa. Nestled in the heart of North Scottsdale’s acclaimed 730-acre master-planned Kierland community, the resort sets an unprecedented standard for offering a complimentary collection of world-class amenities at your fingertips—enjoy premier accommodations, dining, golf, and spa paired with highly sought-after shopping, eateries, and activities located just steps from the resort.
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.
(Pricing subject to change and inclusive of tax)
The Westin Kierland Golf Club presents a thoughtfully distinctive, award-winning brand of golf in which guests are consistently met with an elevated golf experience rich in innovation, one-of-a-kind offerings, and fun new ways to play its 27 Troon-managed holes.
Agave, The Arizona Spa & Salon offers treatments inspired by traditional practices handed down through many of Arizona’s native cultures—paired with therapies infused with healing traditions from the best practices worldwide—to present a refined rejuvenation experience.
One of the resort’s biggest attractions is the Adventure Water Park, which offers the iconic Kierland FlowRider flow-board simulator for surfing in the desert, a lazy river and a 110-foot-long waterslide, and more! Rent a family-friendly poolside cabana to relax in shaded luxury or enjoy your very own Tommy Bahama Relaxation Reef private “island.” Discover a true oasis in Scottsdale.
This vast urban preserve encompasses more than 30,500 acres and boasts 225+ miles of scenic shared-use trails in the McDowell Mountain foothills for hiking, mountain biking, and horseback riding. One of the Preserve’s 11 trailheads, the Gateway is a great place to start your explorations. You’ll find trails for all skill levels, from the ADA-accessible Bajada Nature Trail to the calorie-busting Windgate Pass Trail.
Old Town’s nine walkable neighborhoods offer you a variety of experiences by day and night. Discover Scottsdale’s beginnings in Historic Old Town, browse the galleries of the Arts District during the weekly ArtWalk, shop along Fifth Avenue or discover the energy of Scottsdale after dark in the Entertainment District.
We may be partial, but we think Scottsdale’s great outdoors is greater than most. Our sunny skies and the lush Sonoran Desert create the perfect backdrop for outdoor adventures like hot air ballooning, horseback riding, off-road tours, river rafting, and more. And thanks to our professional guides and outfitters, there’s no experience required to enjoy the best outdoor activities in Scottsdale!
Vanderbilt University School of Medicine
Yale Cancer Center
New Haven, Connecticut
Vancouver Prostate Centre and the University of British Columbia
Vancouver, BC, Canada
University of California San Diego
La Jolla, California
The University of Texas MD Anderson Cancer Center
Johns Hopkins Medicine
Baylor College of Medicine
Providence Saint John’s Health Center
Santa Monica, California
AdventHealth Cancer Institute
Vanderbilt University Medical Center
This activity is approved for 9 AMA PRA Category 1 Credits™
By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.
COVID-19 DISCLAIMER: An inherent risk of exposure to COVID-19 and other more common contagions exists in any public place where people are present. COVID-19 is an extremely contagious disease that can lead to severe illness and even death in a small percentage of the population, especially those with weakened immune systems. For your safety and convenience, we are endeavoring to take appropriate precautions, as detailed above. Even with our best efforts, however, there is no guarantee that you can avoid exposure to COVID-19 or other common pathogens, whether at our conference or elsewhere. Please note that, as further detailed in our Conference Registration and Attendance Terms and Conditions Agreement (the “Registration Agreement”), which must be reviewed and agreed to during the registration process, all conference attendees voluntarily assume ALL RISKS related to any possible exposure to COVID-19. We encourage you to read the Registration Agreement carefully, as it contains other important terms, including other disclaimers and limitations on liability.
1. When is the abstract submission deadline?
October 21, 2022
2. What are the submission guidelines?
When submitting your abstract, please follow these formatting guidelines:
3. How will the posters be displayed?
After your abstract is submitted and approved, please send a recording (3 minutes or shorter, MP4 or MOV format) to email@example.com of someone presenting the poster. This is usually done by an author of the abstract, but is not required. Zoom has an easy self-recording option with screen share for the abstract slides. Please also send bio information about the presenter of the abstract.
4. Who can give the oral poster presentation?
Anyone involved with the poster; does not need to be a lead investigator or healthcare provider. However, please provide the name of the presenter to us in advance, by October 31, 2022, if possible.
5. Are the poster sessions CME accredited?
6. I have other questions, who can I contact?
Greg at firstname.lastname@example.org
To inquire about support opportunities, please contact:
Marc Weathersby, Chief Commercial Officer
Tel:434-817-2000, x193 • Cell: 434-989-5508
Fax 434-817-2020 • email@example.com
Exhibit and Sponsor Prospectus
Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.
Jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd.